Direct answer
Yes. Breast implants can cause health issues, but the risks fall into different categories and should not be treated as if they are all equally established. Well-documented complications include capsular contracture, rupture, pain, infection, sensation changes, implant displacement, and future reoperation. Rare implant-associated cancers are also recognized. Some patients report systemic symptoms referred to as breast implant illness, but the cause is still being studied and a direct causal link is not established for every symptom or patient.
Key Takeaways
- Breast implants are medical devices and are not considered lifetime devices.
- Local complications such as capsular contracture, rupture, pain, infection, and implant displacement are established risks.
- BIA-ALCL is a rare lymphoma associated predominantly with textured implant surfaces. Other rare cancers of the implant capsule have also been reported.
- Systemic symptoms described as breast implant illness are reported by patients, but the mechanism and degree of causation remain uncertain.
- Silicone implants require long-term surveillance for silent rupture, and all patients should continue age-appropriate breast-cancer screening.
Which breast implant health risks are clearly established?
The FDA separates breast implant risks into local device complications, the possibility of additional operations, rare implant-associated cancers, and reported systemic symptoms. That distinction is useful because a ruptured implant and unexplained fatigue are not the same kind of evidence question.
The FDA's breast implant risk guidance lists capsular contracture, rupture or deflation, pain, changes in nipple or breast sensation, implant malposition, infection, fluid collections, tissue thinning, rippling, and the need for additional surgery among recognized complications.
Breast implants should therefore not be described as maintenance-free. The current Adonis breast augmentation page explains that some patients keep implants for many years while others need earlier revision because of rupture, capsular contracture, implant position, tissue changes, or a personal decision to change or remove them.
| Issue | How established is the association? | What patients may notice |
|---|---|---|
| Capsular contracture | Well established | Increasing firmness, distortion, tightness, or breast pain |
| Implant rupture or saline deflation | Well established | Shape change, deflation, lumps, pain, firmness, or no symptoms with silent silicone rupture |
| Infection or fluid collection | Well established | Redness, warmth, fever, swelling, pain, drainage, or persistent fluid |
| BIA-ALCL | Rare but established association, predominantly with textured surfaces | Late persistent swelling, fluid, breast or armpit mass, pain, asymmetry, or hardening |
| Other capsule cancers including SCC | Very rare reports; risk is still being characterized | Late swelling, pain, mass, skin change, or other new breast changes |
| Systemic symptoms / BII | Reported and actively studied; causation remains uncertain | Fatigue, brain fog, joint or muscle pain, rash, hair changes, and other systemic complaints |
| Autoimmune or rheumatic disease | Evidence is mixed | No single symptom pattern proves an implant-related autoimmune disease |
What is capsular contracture?
The body normally forms scar tissue around any implanted device. With breast implants, this scar layer is called the capsule. Capsular contracture occurs when the capsule tightens more than expected and compresses the implant.
Mild contracture may be noticeable mainly as firmness. More advanced contracture can distort breast shape, raise or shift the implant, and cause discomfort or pain. Treatment depends on severity and can include revision surgery, implant exchange or removal, and selected capsule surgery.
Capsular contracture is a local breast complication. It should not be confused with breast implant illness or autoimmune disease.
What happens if a breast implant ruptures?
Saline and silicone implant ruptures behave differently. A saline implant usually loses volume because the saline escapes and is absorbed by the body. The implant shell remains and typically requires surgical removal or replacement.
Silicone rupture may be silent. The FDA notes that neither the patient nor clinician can reliably identify every silicone rupture by appearance or physical examination alone. When silicone escapes the shell, it may remain inside the surrounding capsule or, in some cases, extend beyond it.
The Adonis guide to what happens when a breast implant ruptures covers symptoms, imaging, silicone migration, and the surgical decisions that may follow a confirmed rupture.
What is breast implant illness?
Breast implant illness, commonly shortened to BII, is a term used by patients and clinicians for a broad group of systemic symptoms reported by some people with breast implants. The FDA lists fatigue, memory or concentration problems, joint and muscle pain, hair changes, weight changes, anxiety, depression, rash, and other symptoms among reports it has received.
These symptoms are real experiences, but BII is difficult to study because there is no single diagnostic test and many of the symptoms are common in thyroid disease, autoimmune conditions, anemia, sleep disorders, menopause, chronic pain conditions, medication effects, mood disorders, and other medical problems.
The FDA states that the cause of these symptoms and the degree to which they are related to breast implants are unclear. Symptoms have been reported with saline and silicone implants and across different shapes and surface types.
Do symptoms improve after implant removal?
They can. Recent research gives more useful information than simply saying that BII is either “proven” or “imaginary.”
A prospective ASERF study found that most symptomatic patients reported at least partial improvement one year after implant removal. Importantly, symptom improvement was seen regardless of the type of capsulectomy performed.
A 2025 systematic review and meta-analysis also found that many patients reported improvement after explantation, while emphasizing that BII is likely multifactorial and that the underlying mechanisms remain uncertain.
This means explantation can be a reasonable discussion for a patient with persistent symptoms who wants implants removed, but it should not be presented as a guaranteed cure. Medical evaluation for other causes remains appropriate.
Capsule removal is not automatically “more complete” treatment for systemic symptoms. The extent of capsulectomy should be based on the clinical indication, implant condition, capsule findings, and surgical risk. A confirmed implant-associated cancer is a different situation and can change the required operation.
Do breast implants cause autoimmune disease?
This remains an area of uncertainty rather than a settled yes-or-no question.
The FDA states that it has not detected an association between silicone gel-filled breast implants and connective tissue disease. At the same time, a systematic review of rheumatic disease research found conflicting results and concluded that a small increase in risk for systemic sclerosis and rheumatoid arthritis could not be excluded. The same review found that available studies did not support an association with systemic lupus erythematosus.
That is different from saying implants are proven to cause autoimmune disease. It is also different from saying research has ruled out every possible association. Patients with persistent joint pain, rashes, dry eyes or mouth, unexplained fevers, marked fatigue, or other systemic symptoms should be assessed according to the actual medical presentation.
Do breast implants increase breast cancer risk?
Breast implants are not considered to cause ordinary breast cancer. The FDA states that it has not detected an association between silicone gel-filled implants and breast cancer.
Implant-associated cancers are a separate issue. BIA-ALCL is a lymphoma of the immune system that develops in the fluid or capsule around the implant rather than in breast tissue itself. The association is strongest with textured implant surfaces.
The FDA has also received reports of squamous cell carcinoma and other rare lymphomas arising in the capsule around breast implants. These conditions appear to be very rare, and the true incidence and risk factors are still being defined.
What are the warning signs of BIA-ALCL?
The most important symptoms are persistent swelling or a new fluid collection around an implant, a breast or armpit mass, unexplained pain, increasing asymmetry, or hardening that develops after the initial recovery period, often years after surgery.
The FDA BIA-ALCL guidance emphasizes that these findings should be evaluated rather than treated as routine aging of the implant. Assessment may include examination, imaging, and testing of fluid or capsule tissue when indicated.
BIA-ALCL is uncommon, but it is serious. Prompt evaluation matters because management differs from ordinary implant removal.
How should silicone implants be monitored?
Current FDA guidance recommends ultrasound or MRI to screen asymptomatic silicone implants for silent rupture beginning about five to six years after implantation and then every two to three years thereafter.
If symptoms develop, or if ultrasound findings are unclear, MRI may be used sooner. Saline implants do not have the same routine rupture-screening recommendation because deflation is generally clinically visible.
Implant imaging is separate from breast-cancer screening. Patients should continue mammography or other screening recommended for their age and risk level and should tell the imaging facility that they have breast implants so appropriate implant-displacement techniques can be used.
Are breast implants lifetime devices?
No. The FDA specifically states that breast implants are not lifetime devices and that the longer a person has implants, the greater the chance that a complication may eventually require another operation.
That does not mean every implant must be replaced at ten years or any other fixed anniversary. Some remain intact for much longer. The correct approach is ongoing surveillance and intervention when there is a clinical reason, such as rupture, contracture, malposition, pain, infection, an implant-associated disease, or a patient's preference.
If you are still deciding between implant types, the Adonis guide to saline versus silicone breast implants compares rupture behavior, feel, rippling, FDA age indications, and silicone-imaging requirements.
When should someone with implants contact a doctor?
Contact your surgeon or another qualified clinician for a new or persistent breast change rather than waiting for the next routine visit. Important reasons include:
- persistent swelling or a new fluid collection
- a new breast or armpit mass
- increasing firmness, pain, or distortion
- a sudden or progressive change in breast size or shape
- redness, warmth, drainage, fever, or signs of infection
- new unexplained lymph-node enlargement
- systemic symptoms that are persistent enough to affect daily life
Systemic symptoms should be evaluated broadly. An implant may be part of the clinical discussion, but fatigue, brain fog, muscle pain, or joint pain should not automatically be attributed to an implant before other relevant causes are considered.
What should you ask before getting breast implants?
The FDA requires a boxed warning and Patient Decision Checklist for legally marketed breast implants in the United States. Before surgery, ask for the patient labeling for the exact implant being considered and review it with the surgeon.
Useful questions include which implant surface and fill are proposed, how rupture will be monitored, what symptoms should trigger urgent evaluation, how BIA-ALCL risk applies to the specific device, what additional surgeries may be needed over a lifetime, and what happens if you eventually want the implants removed.
The Adonis guide to questions to ask before breast augmentation covers implant selection, placement, recovery, long-term surveillance, and revision planning in more detail.
Honest limitation: breast implant safety research contains both strong evidence and unresolved questions. Local device complications and BIA-ALCL are well established. Systemic symptoms are widely reported and may improve after explantation, but the mechanism and individual causation remain uncertain. Autoimmune-disease research is mixed and should be described with that uncertainty intact.
Frequently Asked Questions
Can breast implants cause health issues?
Yes. Breast implants can cause established local complications such as capsular contracture, rupture, pain, infection, sensation changes, implant displacement, and the need for additional surgery. They are also associated with rare implant-related cancers. Some patients report systemic symptoms called breast implant illness, although the cause and the degree to which implants are responsible remain uncertain.
What is breast implant illness?
Breast implant illness, or BII, is a patient-used term for systemic symptoms such as fatigue, brain fog, joint or muscle pain, rash, hair changes, and other complaints reported after breast implantation. It is not a single formally defined diagnosis, and no specific test confirms it. Research is ongoing because symptoms are real but can have many potential causes.
Do breast implants cause autoimmune disease?
The evidence is mixed. The FDA states that it has not detected an association between silicone gel implants and connective tissue disease, while systematic reviews note that a small increase in risk for some rheumatic diseases cannot be completely excluded. Patients with persistent systemic symptoms should receive a medical evaluation rather than assuming either that implants are definitely the cause or definitely unrelated.
What are the warning signs of BIA-ALCL?
The most important warning signs are persistent breast swelling, a new fluid collection, a breast or armpit mass, pain, asymmetry, or hardening that develops after the original surgical recovery, often years after implant placement. BIA-ALCL is a lymphoma of the immune system, not breast cancer, and it has been associated predominantly with textured implant surfaces.
Do silicone breast implants need routine imaging?
Yes. Current FDA guidance recommends that people with silicone gel-filled implants have their first ultrasound or MRI for silent rupture about five to six years after implantation, then every two to three years thereafter. If symptoms develop or an ultrasound is inconclusive, MRI may be recommended sooner. These implant-integrity studies do not replace routine breast-cancer screening.
Will removing breast implants cure breast implant illness symptoms?
Some patients report substantial symptom improvement after implant removal, and prospective studies have documented improvement in many self-reported symptoms. Improvement is not guaranteed, and current evidence does not show that one capsulectomy technique is required for symptom relief in every patient. Other medical causes should also be assessed, and the extent of capsule removal should match the clinical indication.
Make the implant decision with the long-term plan in view
The surgical team at Adonis Plastic Surgery can review implant type, surface, size, anatomy, known risks, screening requirements, and the possibility of future revision or removal before breast augmentation. The goal is informed consent that includes both the aesthetic benefit and the long-term responsibilities of having an implanted medical device.
Request a consultationReferences
- U.S. Food and Drug Administration. Risks and Complications of Breast Implants.
- U.S. Food and Drug Administration. Breast Implant Surgery and Patient Decision Checklist.
- Longevity of Post-Explantation Systemic Symptom Improvement: ASERF Systemic Symptoms in Women Study, Part 4.
- Breast Implant Illness: Symptoms, Outcomes With Explantation and Potential Etiologies. Systematic Review and Meta-Analysis. 2025.
- Risk of Rheumatic Disease in Breast Implant Users: A Qualitative Systematic Review.
